Development and Validation of a Risk Score for Mild Cognitive Impairment in Individuals with Type 2 Diabetes in China: A Practical Cognitive Prescreening Tool
Qun Ding,1– 4,* Congcong Yu,2,3,* Xiang Xu,1,3 Yinjiao Hou,1,3 Yingwen Miao,2,3 Sijue Yang,2,3 Shihua Chen,2,3 Xuelin Ma,2,3 Zhou Zhang,2,3 Yan Bi1– 3 1Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital Clinical College of Nanjing...
Main Authors: | Ding Q, Yu C, Xu X, Hou Y, Miao Y, Yang S, Chen S, Ma X, Zhang Z, Bi Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-03-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/development-and-validation-of-a-risk-score-for-mild-cognitive-impairme-peer-reviewed-fulltext-article-DMSO |
Similar Items
-
Risk scores of incident mild cognitive impairment in a Beijing community-based older cohort
by: Xin Li, et al.
Published: (2022-10-01) -
Prescreening of tumor samples for tumor-centric transcriptome analyses of lung adenocarcinoma
by: Nayoung Kim, et al.
Published: (2022-11-01) -
Cerebral Small Vessel Disease is Associated with Mild Cognitive Impairment in Type 2 Diabetes Mellitus
by: Teng Z, et al.
Published: (2022-07-01) -
High Serum Neuron-Specific Enolase Level Is Associated with Mild Cognitive Impairment in Patients with Diabetic Retinopathy
by: Yu ZW, et al.
Published: (2020-04-01) -
Synergy through integration of digital cognitive tests and wearable devices for mild cognitive impairment screening
by: Aoyu Li, et al.
Published: (2023-04-01)